Literature DB >> 9485190

Transendothelial chemotaxis of human alpha/beta and gamma/delta T lymphocytes to chemokines.

S J Roth1, T G Diacovo, M B Brenner, J P Rosat, J Buccola, C T Morita, T A Springer.   

Abstract

Two subpopulations of human T lymphocytes expressing different antigen receptors, alpha/beta and gamma/delta, emigrate into inflamed tissues in distinctive patterns. We compared the transmigration of alpha/beta and gamma/delta T cells to C-C and C-X-C chemokines using an in vitro transendothelial chemotaxis assay. The C-C chemokines monocyte chemoattractant protein (MCP)-1, RANTES, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta stimulated similar, dose-dependent chemotaxis of purified gamma/delta T cells, whereas MCP-1, RANTES, and MIP-1alpha produced greater chemotaxis of purified alpha/beta T cells than MIP-1beta. In contrast, the C-X-C chemokines interleukin (IL)-8 and interferon-gamma inducible protein-10 (IP-10) did not promote chemotaxis of either alpha/beta or gamma/delta T cells. Three gamma/delta T cell clones with differing CD4 and CD8 phenotypes also migrated exclusively to C-C chemokines. Phenotypic analysis of mononuclear cells that transmigrated from an input population of unfractionated peripheral blood mononuclear cells confirmed the results with purified gamma/delta T cells. Our data demonstrate that human peripheral blood alpha/beta and gamma/delta T cells can transmigrate to MCP-1, RANTES, MIP-1alpha, and MIP-1beta, and suggest that both T lymphocyte subpopulations share the capacity to emigrate in response to C-C chemokines during inflammation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9485190     DOI: 10.1002/(SICI)1521-4141(199801)28:01<104::AID-IMMU104>3.0.CO;2-F

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  The mechanism of mononuclear cell infiltration in oral lichen planus: the role of cytokines released from keratinocytes.

Authors:  T Yamamoto; T Nakane; T Osaki
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

Review 2.  Vgamma2Vdelta2+ T cells and anti-microbial immune responses.

Authors:  Zheng W Chen; Norman L Letvin
Journal:  Microbes Infect       Date:  2003-05       Impact factor: 2.700

Review 3.  Adaptive immune response of Vgamma2Vdelta2 T cells: a new paradigm.

Authors:  Zheng W Chen; Norman L Letvin
Journal:  Trends Immunol       Date:  2003-04       Impact factor: 16.687

4.  Prolonged (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-driven antimicrobial and cytotoxic responses of pulmonary and systemic Vgamma2Vdelta2 T cells in macaques.

Authors:  Zahida Ali; Lingyun Shao; Lisa Halliday; Armin Reichenberg; Martin Hintz; Hassan Jomaa; Zheng W Chen
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

5.  CD3 expression distinguishes two gammadeltaT cell receptor subsets with different phenotype and effector function in tuberculous pleurisy.

Authors:  N Yokobori; P Schierloh; L Geffner; L Balboa; M Romero; R Musella; J Castagnino; G De Stéfano; M Alemán; S de la Barrera; E Abbate; M C Sasiain
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

6.  Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma.

Authors:  Liping Song; Tasnim Ara; Hong-Wei Wu; Chan-Wook Woo; C Patrick Reynolds; Robert C Seeger; Yves A DeClerck; Carol J Thiele; Richard Sposto; Leonid S Metelitsa
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

7.  Cutting edge: Vascular endothelial growth factor-mediated signaling in human CD45RO+ CD4+ T cells promotes Akt and ERK activation and costimulates IFN-gamma production.

Authors:  Aninda Basu; Andre Hoerning; Dipak Datta; Monika Edelbauer; Maria P Stack; Katiana Calzadilla; Soumitro Pal; David M Briscoe
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

8.  Immune biology of macaque lymphocyte populations during mycobacterial infection.

Authors:  X Lai; Y Shen; D Zhou; P Sehgal; L Shen; M Simon; L Qiu; N L Letvin; Z W Chen
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

9.  The atypical chemokine receptor D6 contributes to the development of experimental colitis.

Authors:  Yvonne Bordon; Chris A H Hansell; David P Sester; Mairi Clarke; Allan McI Mowat; Robert J B Nibbs
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

Review 10.  Immunotherapeutic approaches for glioma.

Authors:  Hideho Okada; Gary Kohanbash; Xinmei Zhu; Edward R Kastenhuber; Aki Hoji; Ryo Ueda; Mitsugu Fujita
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.